Management of small cell lung cancer

被引:21
作者
Johnson, BE
机构
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1016/S0272-5231(03)00070-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Small-cell lung carcinoma typically presents as a central endobronchial lesion in chronic cigarette smokers with hilar enlargement and disseminated disease. The diagnostic pathology should be reviewed by a pathologist accomplished in reading pulmonary pathology. If any doubts exist in the diagnosis, additional special stains or diagnostic materials should be obtained. The introduction of combination chemotherapy as treatment for this disease has resulted in high response rates and prolonged survival. The management of small-cell lung cancer largely is based on systemic treatment with combination chemotherapy rather than surgical resection, which typically is used for non-small-cell lung cancers.
引用
收藏
页码:225 / +
页数:16
相关论文
共 163 条
[1]  
ABELOFF MD, 1981, CANCER, V48, P1082, DOI 10.1002/1097-0142(19810901)48:5<1082::AID-CNCR2820480505>3.0.CO
[2]  
2-J
[3]   PROSPECTIVE-STUDY OF ETOPOSIDE SCHEDULING IN COMBINATION CHEMOTHERAPY FOR LIMITED DISEASE SMALL-CELL LUNG-CARCINOMA [J].
ABRATT, RP ;
WILLCOX, PA ;
DEGROOT, M ;
GOODMAN, HT ;
JANSEN, ER ;
SALTON, DGM .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (01) :28-30
[4]   DETERMINANTS OF IMPROVED OUTCOME IN SMALL-CELL LUNG-CANCER - AN ANALYSIS OF THE 2,580-PATIENT SOUTHWEST ONCOLOGY GROUP DATA-BASE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1563-1574
[5]   Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: A phase II study in patients with refractory and sensitive disease [J].
Ardizzoni, A ;
Hansen, H ;
Dombernowsky, P ;
Gamucci, T ;
Kaplan, S ;
Postmus, P ;
Giaccone, G ;
Schaefer, B ;
Wanders, J ;
Verweij, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :2090-2096
[6]   PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
BORIE, F ;
RIVIERE, A ;
CHOMY, P ;
MONNET, I ;
TARDIVON, A ;
VIADER, F ;
TARAYRE, M ;
BENHAMOU, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :183-190
[7]   INITIAL CHEMOTHERAPEUTIC DOSES AND SURVIVAL IN PATIENTS WITH LIMITED SMALL-CELL LUNG-CANCER [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
PIGNON, JP ;
RIVIERE, A ;
MONNET, I ;
CHOMY, P ;
TUCHAIS, C ;
TARAYRE, M ;
RUFFIE, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1848-1852
[8]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[9]   The nature of the "oat-celled sarcoma" of the mediastinum. [J].
Barnard, WG .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1926, 29 (03) :241-244
[10]   CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
BISHOP, JF ;
RAGHAVAN, D ;
STUARTHARRIS, R ;
MORSTYN, G ;
ARONEY, R ;
KEFFORD, R ;
YUEN, K ;
LEE, J ;
GIANOUTSOS, P ;
OLVER, IN ;
ZALCBERG, J ;
BALL, D ;
BULL, C ;
FOX, R .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1574-1578